Peterson Linda R, Soto Pablo F, Herrero Pilar, Mohammed B Selma, Avidan Michael S, Schechtman Kenneth B, Dence Carmen, Gropler Robert J
Cardiovascular Division, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
JACC Cardiovasc Imaging. 2008 Jul;1(4):424-33. doi: 10.1016/j.jcmg.2008.05.004.
We sought to determine the gender-specific effects of obesity on myocardial metabolism, work, and efficiency.
Myocardial metabolism abnormalities may contribute to the development of obesity-related heart failure. Increased myocardial oxygen consumption (MVO(2)) and fatty acid (FA) metabolism and decreased efficiency occur with obesity in women. It is unknown whether similar changes occur with obesity in men.
We quantified cardiac work, efficiency, myocardial blood flow (MBF), MVO(2), glucose, and FA metabolism with echocardiography and positron emission tomography in nonobese and obese men and women (N = 86).
There were significant differences between the obese (n = 35) and nonobese (n = 51) subjects in age, body composition, plasma lipids, and insulin resistance in addition to differences between the men (n = 30) and women (n = 56) in body composition and plasma lipids. Female gender independently predicted increased cardiac work (p < 0.001). Female gender also related to lower efficiency (p < 0.05). Obesity and female gender independently predicted greater MBF (p < 0.01, p < 0.0005, respectively) and MVO(2) (p < 0.0005, p < 0.0001). Myocardial glucose uptake was not different among the 4 subject groups, but obesity and gender interacted in predicting glucose uptake (p < 0.05). Lower myocardial glucose utilization was independently predicted by female gender (p < 0.05), and it independently predicted lower myocardial glucose utilization/plasma insulin (p < 0.05). Obesity and gender significantly interacted in the determination of glucose utilization/plasma insulin (p = 0.01). There were no differences in FA uptake among the 4 groups, and although increasing obesity correlated with greater myocardial FA utilization and oxidation; female gender (p < 0.005, p < 0.01) and plasma triglycerides (p < 0.05, p < 0.005) were their independent predictors.
Women's and men's myocardial metabolic responses to obesity are not exactly the same. Obesity and gender modulate MBF and MVO(2), are related to myocardial substrate metabolism, and sometimes interact in its prediction. Gender modifies efficiency. Gender-related differences in myocardial metabolism may affect the development of/adaptation to obesity-related cardiac disease.
我们试图确定肥胖对心肌代谢、做功及效率的性别特异性影响。
心肌代谢异常可能促使肥胖相关心力衰竭的发生。肥胖女性会出现心肌氧耗(MVO₂)增加、脂肪酸(FA)代谢增加及效率降低的情况。尚不清楚肥胖男性是否会出现类似变化。
我们采用超声心动图和正电子发射断层扫描技术,对非肥胖和肥胖男性及女性(N = 86)的心脏做功、效率、心肌血流量(MBF)、MVO₂、葡萄糖及FA代谢进行了量化。
肥胖组(n = 35)和非肥胖组(n = 51)在年龄、身体组成、血脂及胰岛素抵抗方面存在显著差异,此外,男性组(n = 30)和女性组(n = 56)在身体组成和血脂方面也存在差异。女性性别可独立预测心脏做功增加(p < 0.001)。女性性别还与较低的效率相关(p < 0.05)。肥胖和女性性别可独立预测更高的MBF(分别为p < 0.01,p < 0.0005)和MVO₂(分别为p < 0.0005,p < 0.0001)。4组受试者的心肌葡萄糖摄取无差异,但肥胖和性别在预测葡萄糖摄取方面存在相互作用(p < 0.05)。女性性别可独立预测较低的心肌葡萄糖利用(p < 0.05),且可独立预测较低的心肌葡萄糖利用/血浆胰岛素水平(p < 0.05)。肥胖和性别在葡萄糖利用/血浆胰岛素的测定中存在显著相互作用(p = 0.01)。4组之间的FA摄取无差异,尽管肥胖程度增加与更高的心肌FA利用和氧化相关;但女性性别(p < 0.005,p < 0.01)和血浆甘油三酯(p < 0.05,p < 0.005)是其独立预测因素。
男性和女性心肌对肥胖的代谢反应并不完全相同。肥胖和性别可调节MBF和MVO₂,与心肌底物代谢相关,且在预测方面有时存在相互作用。性别可改变效率。心肌代谢的性别相关差异可能影响肥胖相关心脏病的发生/适应。